Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCA-oxycodone after cardiac surgery
2024-515530-33-00Phase 4Authorised
- Sponsor
- Pohjois-Savon hyvinvointialue
- Start
- Mar 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of oxycodone in coronary arteriosclerosis, aortic valve disease (AVD), mitral valve disease and 1 more, sponsored by Pohjois-Savon hyvinvointialue. Planned start Mar 2025; status: authorised.
02
Drugs
oxycodone
03
Conditions
coronary arteriosclerosisaortic valve disease (AVD)mitral valve diseasetricuspid valve disease
Beyond the preview
Go deeper on 2024-515530-33-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-515530-33-00.